![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() by Christen Mccurdy Washington DC (UPI) May 12, 2020
The Department of Defense announced Tuesday that it has awarded a $138 million contract to ApiJect Systems America to create a ready supply chain for prefilled syringes when a COVID-19 vaccine is available. According to the Pentagon, the contract was spearheaded by the DoD's Joint Acquisition Task Force in conjunction with the U.S. Department of Health and Human Services. Under the contract, ApiJect's subsidiary RAPID USA Inc. will operate under the initiative Project Jumpstart to create a U.S.-based high-speed supply chain for prefilled syringes using blow-fill-seal plastics manufacturing technology, enabling the manufacture of medical-grade injection devices by October 2020. "By immediately upgrading a sufficient number of existing domestic BFS facilities with installations of filling-line and technical improvements, 'Jumpstart' will enable the manufacture of more than 100 million prefilled syringes for distribution across the United States by year-end 2020," said Pentagon spokesman Lt. Col. Mike Andrews. According to Andrews, the Jumpstart initiative will enable the manufacture of more than 100 million prefilled syringes for distribution across the United States by the end of the year. ApiJect announced Tuesday that it also plans to ramp up production of syringes in 2021, producing 330 million prefilled BFS syringes per month by the end of the year. "RAPID USA is led by our multi-disciplinary team of experienced engineers, pharmaceutical technology experts, and management leadership. Our team is expending extraordinary efforts to ensure that when drugs are developed and tested all Americans can receive critical injections," said ApiJect Systems America CEO Jay Walker. "We will have done our part by providing the manufacturing capacity to support the necessary volume of ready-to-use prefilled syringes that contain essential medicines, be they therapeutics or vaccines." Initial manufacturing sites will be in Connecticut, South Carolina and Illinois, with potential expansion to other U.S. locations. "RAPID will provide increased lifesaving capability against future national health emergencies that require population-scale vaccine administration on an urgent basis," Andrews said.
![]() ![]() Facebook reveals members of its 'supreme court' for content San Francisco (AFP) May 6, 2020 Facebook on Wednesday announced the first members of its independent "supreme court" empowered to make binding decisions about what content should be allowed or removed at the social network and Instagram. The oversight board is to make final decisions regarding the kinds of posts known to embroil Facebook in controversy about censorship, misinformation or free speech. Facebook public policy director Brent Harris described creation of the board as the "beginning of a fundamental change in the wa ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |